HST Global, Inc. (HSTC)
HST Global, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Virginia Beach, VA, US. The stock last traded at $0.70, up 0.00% on the session, giving a market capitalisation of $99.0M. On trailing twelve-month figures it carries a trailing P/E of -194.44, a net margin of -57.6%. Its beta of -1.24 implies it has historically moved less than the broad market.
HST Global, Inc. operates as a biotechnology firm dedicated to integrated health and wellness. The company establishes and acquires a global network of specialized wellness centers, which offer homeopathic and alternative treatments primarily for patients suffering from advanced-stage cancers. Furthermore, HST Global focuses on the development of homeopathic and alternative therapeutic candidates that are either currently undergoing or have successfully completed clinical trials. These potential treatments are designed to address late-stage cancers as well as various other critical, life-threatening conditions. The company's corporate headquarters are situated in Hampton, Virginia.
HST Global, Inc. is most often compared with the following Healthcare names: